Possible involvement of cathepsin B released by microglia in methylmercury-induced cerebellar pathological changes in

Misao Sakamoto1, Ken-ichiro Miyamoto, Zhou Wu

  • 1Laboratory of Oral Aging Science, Faculty of Dental Sciences, Kyushu University, Maidashi 3-1-1, Fukuoka 812-8582, Japan.

Neuroscience Letters
|July 22, 2008
PubMed

Insights

Cathepsin B (CB) released by activated microglia contributes to methylmercury (MeHg) brain damage. Inhibiting CB with CA074 protected cerebellar granule cells from MeHg toxicity.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Activated microglia release toxic molecules, including cathepsin B (CB).
  • Methylmercury (MeHg) exposure causes cerebellar pathology.

Purpose of the Study:

  • To investigate the role of microglial cathepsin B (CB) in methylmercury (MeHg)-induced cerebellar damage in adult rats.

Main Methods:

  • Rats were treated with MeHg, and pathological changes in the cerebellum were assessed.
  • Cathepsin B levels in activated microglia were measured.
  • The effect of a CB inhibitor (CA074) on MeHg toxicity was evaluated.
  • Primary cultured microglia were used to study CB secretion.

Main Results:

  • MeHg treatment led to progressive pyknotic changes in cerebellar granule cells and microglial activation.
  • Mature cathepsin B levels significantly increased in activated microglia following MeHg exposure.
  • Co-administration of CA074 with MeHg significantly reduced the severity of granule cell damage.
  • Activated microglia in culture secreted mature CB.

Conclusions:

  • Cathepsin B secreted by activated microglia is closely associated with MeHg-induced cerebellar granule cell damage.
  • CA074 treatment may be a potential therapeutic strategy to prevent MeHg neurotoxicity.

Related Concept Videos